Study Stopped
Patients are receiving detailed packet from department and do not feel they need to go online for additional support.
Improving Mental and Physical Health and Decreasing Hospital Readmission After Pancreatectomy Through Enhanced Patient and Caregiver Education and Engagement
1 other identifier
interventional
91
1 country
1
Brief Summary
The study of readmission is in its infancy in the surgical world, and there are no prospective studies, to the investigators' knowledge, evaluating the efficacy of interventions on preventing readmission following pancreatectomy. Undoubtedly, patients and their caregivers will play a key role in any useful intervention to reduce readmission. Therefore, the investigators' approach is to target perioperative education and engagement of patients and their caregivers in the postoperative recovery of pancreatectomy patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2015
CompletedFirst Posted
Study publicly available on registry
December 1, 2015
CompletedStudy Start
First participant enrolled
July 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 8, 2020
CompletedMay 15, 2020
May 1, 2020
2.7 years
November 18, 2015
May 12, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Efficacy of the SAFECARE at Home program as measured by readmission rate
-The investigators hypothesize that the SAFECARE at HOME program intervention will reduce readmission by half (i.e. from 22% to 11%). The investigators will include a total of 225 evaluable patients in the study, randomized in a 2:1 ratio (i.e. 2 patients in the SAFECARE arm for every 1 patient in the standard of care arm). The designed sample size will allow 80% at a 1-sided alpha=0.1 to detect a 50% decrease in 30-day readmission.
30 days
Secondary Outcomes (2)
Effect of the SAFECARE at Home program as measured by the number of follow-up visits
Through 30 day post-discharge
Comparison of quality of life between SAFECARE at Home patients and patients who received standard post-operative care and education as measured by SF-36
Up to 6 months post-discharge
Study Arms (2)
Arm 1: SAFECARE at Home
EXPERIMENTAL* Patients randomized to the intervention arm will be assigned a username and password to access a SAFECARE at Home account via the internet. They will also be emailed a link to the site with their username and password. * The investigators have worked directly with SAFECARE at Home to create customized lessons for patients undergoing pancreatectomy. These lessons are comprehensive and encompass preoperative preparation as well as postoperative recovery and care. This includes videos, printed material, web-based material, and modules that focus on the pre-treatment, treatment, and follow-up care of patients undergoing surgery for pancreatic cancer. * All patients will receive standard pre- and post-operative instructions and care. This will include verbal education about the procedure by the surgeon as well as standard educational patient handouts, which are routinely provided preoperatively to pancreatectomy patients.
Arm 2: Standard of Care
NO INTERVENTION-All patients will receive standard pre- and post-operative instructions and care. This will include verbal education about the procedure by the surgeon as well as standard educational patient handouts, which are routinely provided preoperatively to pancreatectomy patients.
Interventions
Eligibility Criteria
You may qualify if:
- Scheduled for major pancreatectomy (i.e., pancreaticoduodenectomy, total pancreatectomy, or a distal pancreatectomy).
- At least 18 years of age.
- Able to read and understand English (the SAFECARE at Home program is only implemented in English)
- Has internet access.
- Knowledge of the internet and how to use web-based programs.
- Not pregnant or breastfeeding.
- Able to understand and willing to sign an IRB-approved written informed consent document.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Ryan C Fields, M.D.
Washington University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2015
First Posted
December 1, 2015
Study Start
July 20, 2016
Primary Completion
April 4, 2019
Study Completion
April 8, 2020
Last Updated
May 15, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share